isoproterenol and acipimox

isoproterenol has been researched along with acipimox in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19901 (33.33)18.7374
1990's1 (33.33)18.2507
2000's1 (33.33)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Betteridge, DJ; Campbell, RR; Foster, K; McAleer, M; Mundy, D; Reckless, JP; Stirling, C1
Alberti, KG; Christie, AW; Emmison, N; Kraemer, FB; McCormick, DK; Yeaman, SJ1
Fritsche, A; Häring, H; Lehmann, R; Renn, W; Stumvoll, M; Tschritter, O; Wahl, HG1

Other Studies

3 other study(ies) available for isoproterenol and acipimox

ArticleYear
Effects of acipimox, a nicotinic acid derivative, on lipolysis in human adipose tissue and on cholesterol synthesis in human jejunal mucosa.
    Clinical science (London, England : 1979), 1985, Volume: 68, Issue:1

    Topics: Adipose Tissue; Cholesterol; Fatty Acids; Glycerol; Humans; Hypolipidemic Agents; In Vitro Techniques; Intestinal Mucosa; Isoproterenol; Jejunum; Lipolysis; Pyrazines

1985
Mechanism of anti-lipolytic action of acipimox in isolated rat adipocytes.
    Diabetologia, 1996, Volume: 39, Issue:1

    Topics: Adenosine Deaminase; Adipocytes; Animals; Cells, Cultured; Cyclic AMP; Cyclic AMP-Dependent Protein Kinases; Glycerol; Hypolipidemic Agents; Isoproterenol; Kinetics; Lipase; Lipolysis; Male; Pyrazines; Rats; Rats, Wistar; Subcellular Fractions

1996
Leptin levels in humans are acutely suppressed by isoproterenol despite acipimox-induced inhibition of lipolysis, but not by free fatty acids.
    Metabolism: clinical and experimental, 2000, Volume: 49, Issue:3

    Topics: Adult; Blood Glucose; Fat Emulsions, Intravenous; Fatty Acids, Nonesterified; Female; Heparin; Humans; Hypolipidemic Agents; Insulin; Isoproterenol; Leptin; Lipolysis; Male; Pyrazines; Reference Values; Time Factors

2000